Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: ABVC BioPharma(ABVC) the EBIT is -779.53 K (+66.03%);the EPS is -0.0283 (+78.22%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B66.03%
----
----
EPS
-0.028378.22%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf